These findings, together with the observation that in the absence of CD8+ T cells combination therapy did not result in a therapeutic benefit (Fig. 5c), underscore the importance of CD8+ T cells in inducing antitumor responses in the setting of demethylation-mediated tumor cell-intrinsic STING reactivation. Here, CD8A is linked to neoplasm.